U.S. markets open in 7 hours 18 minutes
  • S&P Futures

    4,219.25
    +9.50 (+0.23%)
     
  • Dow Futures

    33,359.00
    +55.00 (+0.17%)
     
  • Nasdaq Futures

    13,352.75
    +41.50 (+0.31%)
     
  • Russell 2000 Futures

    1,981.90
    +5.60 (+0.28%)
     
  • Crude Oil

    93.84
    -0.50 (-0.53%)
     
  • Gold

    1,806.50
    -0.70 (-0.04%)
     
  • Silver

    20.36
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0323
    -0.0002 (-0.02%)
     
  • 10-Yr Bond

    2.8880
    0.0000 (0.00%)
     
  • Vix

    20.20
    +0.46 (+2.33%)
     
  • GBP/USD

    1.2199
    -0.0004 (-0.03%)
     
  • USD/JPY

    133.2440
    +0.2450 (+0.18%)
     
  • BTC-USD

    23,954.34
    -642.61 (-2.61%)
     
  • CMC Crypto 200

    568.91
    -5.83 (-1.02%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    28,513.86
    +694.53 (+2.50%)
     

Why Adaptimmune Therapeutics Stock Is Popping Today

·2 min read
Why Adaptimmune Therapeutics Stock Is Popping Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of the British cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) are having one of their best days in several months today. To put this move into the proper context, the bellwether biotech indices -- the iShares Biotechnology ETF and the SPDR S&P Biotech ETF -- are both essentially flat for the day at the time of this writing. Adaptimmune's shares appear to be perking up in response to the buyout of fellow soft tissue cancer specialist Epizyme (NASDAQ: EPZM) earlier today.